SCHEMBL21167770

SCHEMBL21167770

Nc1ccc(-c2cnn(CCO)c2)nc1N(N)Cc1cc2cnccc2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.41
MET P08581 6/20 0.38
IKBKE Q14164 1/20 0.35
TBK1 Q9UHD2 1/20 0.35
MAPT P10636 2/20 0.34
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33
FGFR4 P22455 1/20 0.33
FGFR3 P22607 1/20 0.33
KDR P35968 1/20 0.33
JAK2 O60674 2/20 0.33
JAK1 P23458 2/20 0.33
TYK2 P29597 2/20 0.33
JAK3 P52333 2/20 0.33
MAP4K1 Q92918 2/20 0.33
KIT P10721 1/20 0.32
FEN1 P39748 1/20 0.32
CYP2C9 P11712 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24590989 0.89 MET (0.43) CYP2A6METIKBKETBK1FGFR1
SCHEMBL21167471 0.85 MET (0.42) METFGFR1FGFR2FGFR4FGFR3
SCHEMBL23127908 0.81 CYP2A6 (0.42) CYP2A6METIKBKETBK1MAPT
SCHEMBL22475975 0.78 MET (0.43) CYP2A6METIKBKETBK1FGFR1
SCHEMBL21171421 0.75 SCD (0.38) METMAPTFGFR1FGFR2FGFR4
SCHEMBL21167772 0.75 MET (0.54) METCYP2C9PDE3BPDE3APDE10A
SCHEMBL22475678 0.75 CYP2A6 (0.41) CYP2A6METIKBKETBK1MAPT
SCHEMBL21167701 0.75 MET (0.37) METFGFR1FGFR2FGFR4FGFR3
SCHEMBL23127970 0.74 MET (0.37) METFGFR1FGFR2FGFR4FGFR3
SCHEMBL16882505 0.73 MET (0.43) CYP2A6METMAPTJAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-B1 CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LTD (CN) 2022-07-06 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed